Cerebra Integrated Technologies (CEREBRAINT)₹2.25−4.66%Computers Hardware & Equipments
In the Jun 2026 quarter (consolidated), Cerebra Integrated Technologies reported sales of ₹0.33 Cr, down 81.7% from Jun 2025, and net profit of −₹6.47 Cr. For the year to Mar 2026, sales were ₹6.01 Cr and net profit −₹71.98 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.95 | 11.99 | 15.22 | 10.18 | 12.19 | 10.76 | 2.53 | 1.80 | 2.22 | 0.83 | 1.15 | 0.33 |
| Expenses | 30.80 | 31.96 | 18.34 | 19.21 | 21.38 | 25.48 | 3.99 | 6.08 | 12.78 | 21.28 | 34.34 | 6.11 |
| Operating Profit | −12.86 | −20.00 | −3.13 | −9.04 | −9.23 | −14.77 | −1.49 | −4.29 | −10.59 | −20.48 | −33.25 | −5.79 |
| OPM % | −71.7% | −167.1% | −20.5% | −89.1% | −75.7% | −137.4% | −58.8% | −239.2% | −478.8% | −2,496.4% | −2,913.2% | −1,812.5% |
| Other Income | 0.02 | −7.95 | 1.32 | 0.03 | −9.66 | −2.04 | −3.66 | −9.56 | −0.21 | 0.00 | 0.02 | 0.00 |
| Interest | 1.69 | 1.72 | 0.97 | 1.53 | 1.64 | 1.57 | 1.59 | 1.64 | 1.89 | 1.96 | 2.05 | 1.99 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | 0.16 | 0.11 | 0.11 | 0.11 | 0.10 | 0.09 |
| Profit before tax | −14.69 | −29.87 | −2.89 | −10.67 | −20.68 | −18.49 | −6.88 | −15.60 | −12.82 | −22.59 | −35.44 | −7.88 |
| Tax % | 10.5% | 0.0% | −306.2% | 0.0% | 0.0% | −55.0% | 12.8% | −9.3% | −24.4% | −25.5% | −11.8% | −17.8% |
| Exceptional items | 0.00 | −8.01 | 0.00 | 0.00 | −9.69 | −2.05 | −3.26 | −9.56 | −0.23 | 0.00 | 0.00 | 0.00 |
| Net Profit | −16.18 | −29.81 | 5.96 | −10.64 | −20.61 | −8.30 | −7.73 | −14.11 | −9.66 | −16.74 | −31.14 | −6.47 |
| EPS (Rs) | −1.34 | −2.47 | 0.50 | −0.89 | −1.71 | −0.67 | −0.65 | −1.17 | −0.81 | −1.39 | −2.58 | −0.54 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 238 | 250 | 314 | 385 | 182 | 70.04 | 231 | 86.05 | 50.03 | 36.04 | 6.01 | 4.53 |
| Expenses | 236 | 237 | 272 | 343 | 149 | 60.99 | 188 | 76.02 | 88.02 | 69.98 | 73.99 | 74.51 |
| Operating Profit | 2.01 | 13.01 | 42.04 | 42.01 | 33.03 | 9.01 | 41.99 | 10.01 | −38.05 | −35.01 | −69.08 | −70.11 |
| OPM % | 0.9% | 5.0% | 12.9% | 11.0% | 17.9% | 12.0% | 18.0% | 11.0% | −75.0% | −97.1% | −1,152.1% | −1,547.7% |
| Other Income | 3.01 | 1.01 | 2.01 | −18.01 | −14.99 | 0.00 | 4.99 | 0.00 | −12.01 | −15.01 | −10.01 | −0.19 |
| Interest | 3.01 | 1.01 | 2.01 | 4.02 | 3.01 | 4.01 | 6.01 | 10.04 | 6.02 | 6.02 | 8.03 | 7.89 |
| Depreciation | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 |
| Profit before tax | 2.01 | 13.04 | 42.12 | 20.07 | 14.04 | 4.01 | 40.15 | 0.00 | −56.17 | −57.17 | −86.27 | −78.73 |
| Tax % | 17.1% | 7.0% | 17.1% | 71.0% | 15.1% | 68.1% | 32.1% | −1,474.9% | −13.0% | −15.9% | −16.9% | — |
| Exceptional items | −1.01 | 0.00 | 0.00 | −6.01 | −13.01 | 0.00 | 0.00 | 0.00 | −13.01 | −15.02 | −10.01 | −0.23 |
| Net Profit | 2.01 | 11.99 | 35.03 | 6.01 | 11.99 | 1.01 | 27.01 | 2.99 | −48.02 | −47.04 | −71.98 | −64.01 |
| EPS (Rs) | 0.18 | 1.05 | 2.70 | 0.37 | 0.95 | 0.15 | 2.27 | 0.22 | −4.00 | −3.91 | −5.92 | −5.32 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 84.16 | 96.12 | 108 | 120 | 121 | 121 | 121 | 112 | 112 | 112 | 112 | 112 |
| Reserves | 49.12 | 52.08 | 66.01 | 136 | 147 | 173 | 171 | 146 | 148 | 100 | 53.05 | −18.96 |
| Borrowings | 40.02 | 18.99 | 2.99 | 3.00 | 3.99 | 12.96 | 17.99 | 31.97 | 40.93 | 38.97 | 39.99 | 43.96 |
| Other Liabilities | 59.28 | 14.07 | 156 | 105 | 194 | 142 | 73.34 | 136 | 98.47 | 101 | 53.25 | 51.24 |
| Total Liabilities | 232 | 181 | 333 | 364 | 467 | 449 | 385 | 426 | 400 | 353 | 258 | 189 |
| Fixed Assets | 6.98 | 5.98 | 5.98 | 8.98 | 8.97 | 8.97 | 9.96 | 9.97 | 9.97 | 8.97 | 11.97 | 10.97 |
| CWIP | 0.00 | 0.00 | 2.99 | 0.00 | 0.00 | 67.94 | 72.95 | 2.99 | 2.99 | 2.99 | 0.00 | 0.00 |
| Investments | 0.00 | 1.01 | 0.00 | 14.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 225 | 174 | 324 | 341 | 457 | 372 | 302 | 413 | 387 | 341 | 246 | 177 |
| Inventories | 17.06 | 2.01 | 2.01 | 15.06 | 4.02 | 12.05 | 26.11 | 23.08 | 46.18 | 30.12 | 10.04 | 0.00 |
| Trade receivables | 97.85 | 61.94 | 216 | 201 | 339 | 249 | 170 | 189 | 140 | 120 | 73.96 | 5.99 |
| Cash & equivalents | 65.10 | 70.08 | 70.14 | 75.06 | 77.15 | 18.04 | 6.01 | 2.01 | 2.01 | 1.01 | 0.00 | 0.00 |
| Total Assets | 232 | 181 | 333 | 364 | 467 | 449 | 385 | 426 | 400 | 353 | 258 | 189 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −6.02 | 13.03 | 3.01 | −30.11 | −20.05 | −10.03 | −5.02 | −17.06 | −2.01 | 2.01 | 4.01 |
| Cash from investing activity | 0.00 | 1.01 | −3.01 | −17.05 | 19.05 | −52.16 | −9.03 | 0.00 | −1.01 | 3.01 | 1.01 |
| Cash from financing activity | 68.86 | −8.98 | −0.99 | 50.90 | 0.00 | 0.99 | −5.99 | 3.99 | 1.99 | −2.99 | −5.99 |
| Net cash flow | 63.20 | 5.02 | −1.01 | 4.02 | −1.01 | −61.27 | −21.06 | −14.05 | 0.00 | 2.01 | −1.01 |
| Capex | 0.32 | 0.00 | 3.15 | 0.35 | 0.40 | 68.45 | 5.90 | 0.27 | 0.37 | 0.03 | 0.00 |
| Free cash flow | −6.01 | 15.01 | 0.00 | −29.97 | −19.99 | −78.90 | −11.01 | −17.98 | −1.99 | 3.99 | 4.01 |
| CFO / OP % | −80.0% | 609.0% | 29.0% | −53.0% | −31.0% | −23.0% | −32.0% | −41.0% | −3.0% | −11.0% | −12.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 135 | 97 | 316 | 234 | 322 | 500 | 890 | 300 | 597 | 877 | 760 | 380 |
| Inventory days | 25 | 3 | 3 | 21 | 4 | 33 | 211 | 47 | 268 | 236 | 128 | 0 |
| Days payable | 71 | 15 | 246 | 133 | 192 | 301 | 289 | 185 | 309 | 429 | 137 | — |
| Cash conversion cycle | 86 | 83 | 70 | 120 | 132 | 230 | 810 | 160 | 555 | 682 | 748 | 378 |
| Working capital days | 80 | 77 | 93 | 139 | 153 | 265 | 618 | 136 | 370 | 372 | 306 | −3,096 |
| ROCE % | 4.0% | 3.0% | 8.0% | 20.1% | 17.1% | 12.1% | 3.0% | 15.1% | 3.0% | −13.0% | −14.9% | −41.0% |
For the Jun 2026 quarter, Cerebra Integrated Technologies reported sales of ₹0.33 Cr, down 81.7% year on year and net profit of −₹6.47 Cr. The operating margin was −1,812.5%.
Cerebra Integrated Technologies' sales for the year to Mar 2026 were ₹6.01 Cr; over the last twelve months they were ₹4.53 Cr.
Net profit for the year to Mar 2026 was −₹71.98 Cr, and −₹64.01 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−5.32.
Cerebra Integrated Technologies reported borrowings of ₹43.96 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was ₹4.01 Cr in the year to Mar 2025; after capital spending, free cash flow was ₹4.01 Cr.